Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Intermolecular

Explore full profile

High productivity combinatorial (hpc) technology products and services for a wide range of industries

San Jose, United StatesFounded 2004Biotech & Life Sciences
Valuation $90M Market cap · 2011
Revenue $10–50M Latest reported FY
EBITDA $7.0M Latest reported FY

About Intermolecular

Intermolecular, Inc. operates as a crucial partner in the materials innovation sector, specializing in the exploration, testing, and development of advanced materials that underpin next-generation electronics. The company was founded in 2004 by David Lazovsky, who brought extensive experience from the semiconductor equipment industry, having previously worked at Applied Materials. His background in semiconductor technology directly informed Intermolecular's approach to accelerating research and development through a combination of proprietary high-throughput combinatorial processing tools and advanced data analytics. This methodology allows for the rapid testing of a vast number of material combinations, significantly reducing the time and cost associated with bringing new materials to market.

The firm's business model is centered on providing services to semiconductor and electronics manufacturers, helping them overcome complex materials challenges. Intermolecular's core offering is its High-Throughput Experimentation (HTE) platform, which integrates hardware, software, and data analytics to streamline the materials discovery process. Clients leverage this platform to accelerate their own R&D cycles, improve device performance, and secure intellectual property. Revenue is primarily generated through collaborative development programs and licensing of its technology and intellectual property. This approach positions the company as an external R&D arm for its clients, offering specialized expertise and infrastructure that might be prohibitive to develop in-house.

A significant milestone in the company's history was its acquisition by Merck KGaA, Darmstadt, Germany, in 2019, for approximately $62 million. This transaction transformed Intermolecular into the Silicon Valley science hub for Merck's Performance Materials business, now part of its Electronics division. The acquisition was a strategic move by Merck to bolster its capabilities in data analytics and materials informatics, particularly for the electronics industry. For Intermolecular, becoming part of a global science and technology company provided access to greater resources and a broader market, allowing it to continue breaking boundaries in materials science while contributing to Merck's larger mission of advancing digital living.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2004
Headquarters
San Jose, United States
Listing
IPO 2011
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later1 investor entered at this stage

  • Symyx
Team profiled 34 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
170 monthly visits
across markets
🇺🇸 United States117.6%
Top 1 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Intermolecular on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Intermolecular on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.